Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | F2R | P25116 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10014679 | 0.84 | MEN1 (0.53) | ADRA1DADRA1AADRA1BKMT2ATP53 | |
| SCHEMBL12334145 | 0.84 | UTS2R (0.48) | KMT2ATP53CLCN2HPGDMEN1 | |
| SCHEMBL6647138 | 0.82 | TP53 (0.55) | ADRA1DADRA1AADRA1BTP53CLCN2 | |
| SCHEMBL17450382 | 0.81 | L3MBTL1 (0.49) | KMT2ATP53CLCN2HPGDALDH1A1 | |
| SCHEMBL15343524 | 0.81 | KMT2A (0.67) | ADRA1DADRA1AADRA1BKMT2ATP53 | |
| SCHEMBL3628079 | 0.79 | KDM4E (0.53) | ADRA1DADRA1AADRA1BKMT2ATP53 | |
| SCHEMBL255338 | 0.79 | KMT2A (0.54) | ADRA1DADRA1AADRA1BKMT2ATP53 | |
| SCHEMBL15265666 | 0.79 | MAPT (0.48) | ADRA1DADRA1AADRA1BKMT2ATP53 | |
| SCHEMBL16395318 | 0.78 | TP53 (0.46) | KMT2ATP53CLCN2HPGDUTS2R | |
| SCHEMBL9516908 | 0.78 | TP53 (0.46) | TP53CLCN2HPGDALDH1A1UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240423201-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | LI WENJIE (CN) | 2024-12-26 | — | — | US | claimed |
| EP-4480307-A1 | PORTABLE ELECTRIC HEATING MOSQUITO REPELLING APPARATUS | Li, Wenjie (CN) | 2024-12-25 | — | — | EP | claimed |
| EP-4480313-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | Li, Wenjie (CN) | 2024-12-25 | — | — | EP | claimed |
| US-20240065253-A1 | PORTABLE ELECTRIC HEATING MOSQUITO REPELLING APPARATUS | LI WENJIE (CN) | 2024-02-29 | — | — | US | claimed |
| EP-3324930-B1 | DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF | DFB SORIA LLC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-12329858-B2 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | CRITITECH, INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-20240423201-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | LI WENJIE (CN) | 2024-12-26 | — | — | US | disclosed |
| US-20240423201-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | LI WENJIE (CN) | 2024-12-26 | — | — | US | disclosed |
| EP-4480307-A1 | PORTABLE ELECTRIC HEATING MOSQUITO REPELLING APPARATUS | Li, Wenjie (CN) | 2024-12-25 | — | — | EP | disclosed |
| EP-4480313-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | Li, Wenjie (CN) | 2024-12-25 | — | — | EP | disclosed |
| EP-4480313-A1 | MULTI-TEMPERATURE ZONE MOSQUITO PREVENTION AND CONTROL TABLET | Li, Wenjie (CN) | 2024-12-25 | — | — | EP | disclosed |
| CN-119139479-A | Compositions comprising taxane nanoparticles and uses thereof | DFB索里亚有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-105232412-A | Mosquito repellent liquid and preparation method thereof | CHEN YIHUA | 2016-01-13 | — | — | CN | disclosed |
| CN-105232414-A | Mosquito repellent and preparation method thereof | CHEN YIHUA | 2016-01-13 | — | — | CN | disclosed |
| EP-2411032-B1 | PLANT EXTRACTS FOR THE TREATMENT OF SKIN DISEASES | EVORIA GMBH (DE) | 2014-07-09 | — | — | EP | disclosed |
| CN-102204962-B | Preparation method of itching-relieving mosquito repellent aerogel patch | ZHEJIANG YIDING MEDICAL DRESSING CO LTD | 2013-03-20 | — | — | CN | disclosed |
| US-20120269914-A1 | PLANT EXTRACTS FOR TREATING SKIN DISEASES | EVORIA GMBH (DE) | 2012-10-25 | — | — | US | disclosed |
| EP-2411032-A2 | PLANT EXTRACTS FOR TREATING SKIN DISEASES | Evoria GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| CN-102204962-A | Preparation method of itching-relieving mosquito repellent colloid application | ZHEJIANG YIDING MEDICAL DRESSING CO LTD | 2011-10-05 | — | — | CN | disclosed |
| WO-2010108488-A2 | PLANT EXTRACTS FOR TREATING SKIN DISEASES | EVORIA GMBH (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12329858-B2 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | TP53, IPO5, NUP205 | ADRA1D 4322/4885ADRA1A 3815/4885ADRA1B 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.